1Tihan T,Barletta J,Parney I,et al.Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy:should pathology evaluation alter treatment decisions?[J].Hum Pathol,2006,37(3):272-82.
3Chekhonin VP,Baklaushev VP,Yusubalieva GM,et al.Targeted transport of 1251-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma[J].J Neuroimmune Pharmacol,2009,4(1):28-34.
4Verhoeff JJ,Stalpers LJ,Claes A,et al.Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma[J].Eur J Cancer,2009,45(17):3074-3080.
5Julow J,Major T,Emri M,et al.The application of image fusion in stereotactic brachytherapy of brain tunours[J].Acta Neurochir (Wien),2000,142(11):1253-1258.
6Chang CN,Chen WC,Wei KC,et al.High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes[J].J Neurooncol,2003,61 (1):45-55.
7Janzer RC.Neuropathology and molecular pathology of gliomas[J].Rev Med Suisse,2009,5(211):1501-1504.
2Ohgaki H, Kleihues P. Popultion-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas[J]. J Neuropathol Exp Neurol, 2005, 64(6): 479-489.
3Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series corrected: brain and other central nervous system cancers: recent trends in incidence and mortality[J]. J Natl Cancer Inst, 1999, 91 (16): 1382-1390.
4Stadlbauer A, Nimsky C, Gruber S, et al. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study[J]. AJNR, 2007, 28(3): 462-469.
5Ciccarelli O, Toosy AT, Parker GJ, et al. Diffusion tractography based group mapping of major white-matter pathways in the human brain[J]. Neuroimage, 2003, 19(4): 1545-1555.
6Yu CS, Li KC, Xuan Y, et al. Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment[J]. Eur J Radiol, 2005, 56 (2): 197-204.
7Kleihues P, Sobin LH. World Health Organization classification of tumors[J]. Cancer, 2000, 88(12): 2887.
8Price S J, Jena R, Burnet NG et al. Predicting patterns of glioma recurrence using diffusion tensor imaging[J]. Eur Radiol, 2007, 17 (7): 1675-1684.
9Witwer BP, Moftakhar R, Hasan KM, et al. Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm [J]. J Neurosurg, 2002, 97(3): 568-575.
10Price S, Burnet N, Donovan T, et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract infiltration?[J]. Clin Radiol, 2003, 58(6): 455-462.
8Fabrini MG,Perrone F,De Franco L. Perioperative high-doserate brachytherapy in the treatment of recurrent malignant gliomas[J].{H}Strahlentherapie und Onkologie,2009,(08):524-529.
9JanzerRC. Neuropathology and molecular pathologyofgliomas[J].Revue Medicale Suisse,2009,(211):1501-1504.
